<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    EyePoint Pharmaceuticals, Inc.

    EyePoint Pharmaceuticals, Inc.

    EyePoint Pharmaceuticals, Inc. is a specialty biopharmaceutical company committed ...

    EyePoint Pharmaceuticals, Inc. is a specialty b...

    Filing Type:    PU
    ACADIA Pharmaceuticals

    ACADIA Pharmaceuticals

    At ACADIA (NASDAQ: ACAD), we share a passion for improving the lives of patients w...

    At ACADIA (NASDAQ: ACAD), we share a passion fo...

    Filing Type:    PU
    Innovation Pharmaceuticals Inc.

    Innovation Pharmaceuticals Inc.

    Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pha...

    Established in 2007, and headquartered in Wakef...

    Filing Type:    PU
    Synthorx, Inc.

    Synthorx, Inc.

    Synthorx is a biotechnology company focused on prolonging and improving the lives ...

    Synthorx is a biotechnology company focused on ...

    Filing Type:    PU
    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    DelMar Pharmaceuticals, Inc.

    DelMar Pharmaceuticals, Inc.

    DelMar Pharmaceuticals is a biopharmaceutical company focused on the development a...

    DelMar Pharmaceuticals is a biopharmaceutical c...

    Filing Type:    PU
    Corvus Pharmaceuticals, Inc.

    Corvus Pharmaceuticals, Inc.

    Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company. We ...

    Corvus Pharmaceuticals is a clinical science-dr...

    Filing Type:    PU
    Sesen Bio, Inc.

    Sesen Bio, Inc.

    At Sesen Bio, we are committed to renewing life for people with cancer. We are a l...

    At Sesen Bio, we are committed to renewing life...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.